

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.55406492 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.55406492 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.31136709 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.31136709 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.92552255 |
| 6 | lysine metabolic process (GO:0006553) | 5.79821164 |
| 7 | lysine catabolic process (GO:0006554) | 5.79821164 |
| 8 | glyoxylate metabolic process (GO:0046487) | 5.60027527 |
| 9 | actin-myosin filament sliding (GO:0033275) | 5.54798758 |
| 10 | muscle filament sliding (GO:0030049) | 5.54798758 |
| 11 | cysteine metabolic process (GO:0006534) | 5.53531813 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 5.42422953 |
| 13 | tryptophan catabolic process (GO:0006569) | 5.39417902 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 5.39417902 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 5.39417902 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.26931790 |
| 17 | kynurenine metabolic process (GO:0070189) | 5.19445885 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.19043527 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.17405619 |
| 20 | tryptophan metabolic process (GO:0006568) | 5.07713612 |
| 21 | bile acid biosynthetic process (GO:0006699) | 4.96351512 |
| 22 | regulation of relaxation of muscle (GO:1901077) | 4.90931569 |
| 23 | regulation of skeletal muscle contraction (GO:0014819) | 4.90661913 |
| 24 | homocysteine metabolic process (GO:0050667) | 4.86097654 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 4.82104809 |
| 26 | amino-acid betaine metabolic process (GO:0006577) | 4.78641637 |
| 27 | short-chain fatty acid metabolic process (GO:0046459) | 4.68521638 |
| 28 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.66819821 |
| 29 | valine metabolic process (GO:0006573) | 4.57555036 |
| 30 | cellular ketone body metabolic process (GO:0046950) | 4.57483573 |
| 31 | fatty acid beta-oxidation (GO:0006635) | 4.51270586 |
| 32 | alpha-amino acid catabolic process (GO:1901606) | 4.48335056 |
| 33 | urea metabolic process (GO:0019627) | 4.45974769 |
| 34 | urea cycle (GO:0000050) | 4.45974769 |
| 35 | acetyl-CoA metabolic process (GO:0006084) | 4.44071901 |
| 36 | aspartate family amino acid catabolic process (GO:0009068) | 4.42013665 |
| 37 | actin-mediated cell contraction (GO:0070252) | 4.41825207 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.40461206 |
| 39 | complement activation, alternative pathway (GO:0006957) | 4.35092311 |
| 40 | cellular modified amino acid catabolic process (GO:0042219) | 4.32036762 |
| 41 | fatty acid oxidation (GO:0019395) | 4.31117721 |
| 42 | cellular amino acid catabolic process (GO:0009063) | 4.30355335 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.29685336 |
| 44 | lipid oxidation (GO:0034440) | 4.26857257 |
| 45 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.23734291 |
| 46 | urate metabolic process (GO:0046415) | 4.20469069 |
| 47 | branched-chain amino acid catabolic process (GO:0009083) | 4.19744516 |
| 48 | bile acid metabolic process (GO:0008206) | 4.16547472 |
| 49 | nitrogen cycle metabolic process (GO:0071941) | 4.16517196 |
| 50 | high-density lipoprotein particle remodeling (GO:0034375) | 4.16149751 |
| 51 | drug transmembrane transport (GO:0006855) | 4.14866742 |
| 52 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.13175869 |
| 53 | fatty acid catabolic process (GO:0009062) | 4.13045441 |
| 54 | glutamate metabolic process (GO:0006536) | 4.12097720 |
| 55 | branched-chain amino acid metabolic process (GO:0009081) | 4.09604793 |
| 56 | tyrosine metabolic process (GO:0006570) | 4.05885674 |
| 57 | ethanol oxidation (GO:0006069) | 4.04781286 |
| 58 | epoxygenase P450 pathway (GO:0019373) | 4.04370024 |
| 59 | protein carboxylation (GO:0018214) | 4.02836454 |
| 60 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.02836454 |
| 61 | monocarboxylic acid catabolic process (GO:0072329) | 4.02409095 |
| 62 | serine family amino acid metabolic process (GO:0009069) | 4.01610132 |
| 63 | regulation of protein activation cascade (GO:2000257) | 3.99994894 |
| 64 | carnitine metabolic process (GO:0009437) | 3.99600398 |
| 65 | ketone body metabolic process (GO:1902224) | 3.98526525 |
| 66 | organic acid catabolic process (GO:0016054) | 3.98109148 |
| 67 | carboxylic acid catabolic process (GO:0046395) | 3.98109148 |
| 68 | creatine metabolic process (GO:0006600) | 3.97523733 |
| 69 | * 2-oxoglutarate metabolic process (GO:0006103) | 3.97361464 |
| 70 | negative regulation of fibrinolysis (GO:0051918) | 3.97037058 |
| 71 | drug catabolic process (GO:0042737) | 3.94156644 |
| 72 | coenzyme catabolic process (GO:0009109) | 3.93587903 |
| 73 | biotin metabolic process (GO:0006768) | 3.93215545 |
| 74 | acylglycerol homeostasis (GO:0055090) | 3.90075736 |
| 75 | triglyceride homeostasis (GO:0070328) | 3.90075736 |
| 76 | reverse cholesterol transport (GO:0043691) | 3.88632688 |
| 77 | myofibril assembly (GO:0030239) | 3.88292150 |
| 78 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.87370223 |
| 79 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.83421197 |
| 80 | plasma lipoprotein particle clearance (GO:0034381) | 3.81090584 |
| 81 | regulation of fibrinolysis (GO:0051917) | 3.80165948 |
| 82 | regulation of complement activation (GO:0030449) | 3.77885430 |
| 83 | serine family amino acid biosynthetic process (GO:0009070) | 3.77066187 |
| 84 | indolalkylamine metabolic process (GO:0006586) | 3.76539994 |
| 85 | protein-lipid complex remodeling (GO:0034368) | 3.76519276 |
| 86 | macromolecular complex remodeling (GO:0034367) | 3.76519276 |
| 87 | plasma lipoprotein particle remodeling (GO:0034369) | 3.76519276 |
| 88 | skeletal muscle contraction (GO:0003009) | 3.75551042 |
| 89 | regulation of cholesterol esterification (GO:0010872) | 3.71772970 |
| 90 | amine catabolic process (GO:0009310) | 3.71097294 |
| 91 | cellular biogenic amine catabolic process (GO:0042402) | 3.71097294 |
| 92 | benzene-containing compound metabolic process (GO:0042537) | 3.68056263 |
| 93 | cellular glucuronidation (GO:0052695) | 3.64118506 |
| 94 | fatty acid transmembrane transport (GO:1902001) | 3.63029073 |
| 95 | negative regulation of sterol transport (GO:0032372) | 3.61086609 |
| 96 | negative regulation of cholesterol transport (GO:0032375) | 3.61086609 |
| 97 | glycine metabolic process (GO:0006544) | 3.60989975 |
| 98 | tricarboxylic acid metabolic process (GO:0072350) | 3.58158680 |
| 99 | exogenous drug catabolic process (GO:0042738) | 3.57793097 |
| 100 | positive regulation of lipid catabolic process (GO:0050996) | 3.57447671 |
| 101 | positive regulation of fatty acid oxidation (GO:0046321) | 3.51741996 |
| 102 | phospholipid homeostasis (GO:0055091) | 3.51448337 |
| 103 | regulation of cholesterol homeostasis (GO:2000188) | 3.49149174 |
| 104 | drug transport (GO:0015893) | 3.46407240 |
| 105 | omega-hydroxylase P450 pathway (GO:0097267) | 3.46217047 |
| 106 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.44055615 |
| 107 | regulation of sequestering of triglyceride (GO:0010889) | 3.43645782 |
| 108 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.41458802 |
| 109 | phospholipid efflux (GO:0033700) | 3.41128926 |
| 110 | regulation of actin filament-based movement (GO:1903115) | 3.38256760 |
| 111 | small molecule catabolic process (GO:0044282) | 3.35828633 |
| 112 | striated muscle contraction (GO:0006941) | 3.35705367 |
| 113 | carnitine transport (GO:0015879) | 3.33581788 |
| 114 | amino-acid betaine transport (GO:0015838) | 3.33581788 |
| 115 | carnitine transmembrane transport (GO:1902603) | 3.32867251 |
| 116 | regulation of cholesterol metabolic process (GO:0090181) | 3.32428247 |
| 117 | carnitine shuttle (GO:0006853) | 3.31358096 |
| 118 | sarcomere organization (GO:0045214) | 3.30484749 |
| 119 | regulation of bile acid biosynthetic process (GO:0070857) | 3.30430962 |
| 120 | glucuronate metabolic process (GO:0019585) | 3.29922089 |
| 121 | uronic acid metabolic process (GO:0006063) | 3.29922089 |
| 122 | cardiac myofibril assembly (GO:0055003) | 3.29811861 |
| 123 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.29737671 |
| 124 | ethanol metabolic process (GO:0006067) | 3.29345744 |
| 125 | oxidative demethylation (GO:0070989) | 3.27629499 |
| 126 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.26011180 |
| 127 | blood coagulation, intrinsic pathway (GO:0007597) | 3.21104557 |
| 128 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.18530517 |
| 129 | regulation of cell communication by electrical coupling (GO:0010649) | 3.12163266 |
| 130 | actin filament-based movement (GO:0030048) | 3.10061165 |
| 131 | cardiac muscle contraction (GO:0060048) | 3.06440397 |
| 132 | S-adenosylmethionine metabolic process (GO:0046500) | 3.03053062 |
| 133 | response to inactivity (GO:0014854) | 2.97720193 |
| 134 | oxaloacetate metabolic process (GO:0006107) | 2.95139909 |
| 135 | quaternary ammonium group transport (GO:0015697) | 2.94554459 |
| 136 | response to muscle activity (GO:0014850) | 2.93475256 |
| 137 | regulation of striated muscle contraction (GO:0006942) | 2.81373633 |
| 138 | glycogen catabolic process (GO:0005980) | 2.81198876 |
| 139 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.80474061 |
| 140 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.80474061 |
| 141 | drug metabolic process (GO:0017144) | 2.80007371 |
| 142 | cellular polysaccharide catabolic process (GO:0044247) | 2.78561682 |
| 143 | xenobiotic catabolic process (GO:0042178) | 2.72207073 |
| 144 | regulation of germinal center formation (GO:0002634) | 2.70726230 |
| 145 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.69504506 |
| 146 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.69504506 |
| 147 | response to mercury ion (GO:0046689) | 2.65705522 |
| 148 | NADH metabolic process (GO:0006734) | 2.64244016 |
| 149 | glucan catabolic process (GO:0009251) | 2.60567903 |
| 150 | cardiac muscle hypertrophy (GO:0003300) | 2.60398733 |
| 151 | muscle contraction (GO:0006936) | 2.57347627 |
| 152 | phenylpropanoid metabolic process (GO:0009698) | 2.57152807 |
| 153 | quinone biosynthetic process (GO:1901663) | 2.56774782 |
| 154 | heart contraction (GO:0060047) | 2.51781748 |
| 155 | heart process (GO:0003015) | 2.51781748 |
| 156 | striated muscle hypertrophy (GO:0014897) | 2.50269542 |
| 157 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.49697581 |
| 158 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.49261934 |
| 159 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.49261934 |
| 160 | polysaccharide catabolic process (GO:0000272) | 2.48973535 |
| 161 | regulation of lipoprotein metabolic process (GO:0050746) | 2.46975265 |
| 162 | ubiquinone biosynthetic process (GO:0006744) | 2.46146802 |
| 163 | response to vitamin E (GO:0033197) | 2.44927269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.35784391 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.07824373 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.28598860 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.82138827 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.36803346 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.34588838 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.68185224 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.78656776 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.68399492 |
| 10 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.22462927 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.99137455 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.27969914 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.13766377 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01973241 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.2756511 |
| 16 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.95849768 |
| 17 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91975431 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.86840032 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.78517155 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.76508926 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.69847237 |
| 22 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.66437999 |
| 23 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60017096 |
| 24 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.59803630 |
| 25 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.59106883 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.56896506 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.48722052 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45548499 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.43797606 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40099397 |
| 31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38433885 |
| 32 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33694738 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33200800 |
| 34 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28429225 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.28136031 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.26752016 |
| 37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25380183 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23311369 |
| 39 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17997969 |
| 40 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15533083 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.15064416 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14879026 |
| 43 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13598004 |
| 44 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10288316 |
| 45 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.08707595 |
| 46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08429325 |
| 47 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.08298457 |
| 48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.07895049 |
| 49 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07814982 |
| 50 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.07668698 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06690592 |
| 52 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06263935 |
| 53 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.05324629 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04325644 |
| 55 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98896669 |
| 56 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.98480134 |
| 57 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.95906919 |
| 58 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95420016 |
| 59 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.93793422 |
| 60 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93279846 |
| 61 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.92274476 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92050476 |
| 63 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91458628 |
| 64 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91200411 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90826730 |
| 66 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90628576 |
| 67 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.90533685 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90361933 |
| 69 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89914646 |
| 70 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.89332136 |
| 71 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.87996359 |
| 72 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.87330982 |
| 73 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.87235762 |
| 74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86839672 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86839672 |
| 76 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.86801727 |
| 77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86485791 |
| 78 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.86396813 |
| 79 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.86396813 |
| 80 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85352005 |
| 81 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85352005 |
| 82 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.85005967 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84687344 |
| 84 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.84501587 |
| 85 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83608266 |
| 86 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.83561883 |
| 87 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.83455434 |
| 88 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.83377216 |
| 89 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.82832126 |
| 90 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.82709026 |
| 91 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82380397 |
| 92 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.82118719 |
| 93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.81952115 |
| 94 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.81921791 |
| 95 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.81590341 |
| 96 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.81336837 |
| 97 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.81336837 |
| 98 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.81292222 |
| 99 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80568300 |
| 100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.80484023 |
| 101 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.79763370 |
| 102 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.79426864 |
| 103 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.79418006 |
| 104 | MYB_26560356_Chip-Seq_TH2_Human | 0.79111181 |
| 105 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.78584423 |
| 106 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.78580457 |
| 107 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.78387953 |
| 108 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78267764 |
| 109 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.78245492 |
| 110 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.77427506 |
| 111 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.77313165 |
| 112 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.77158336 |
| 113 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.77144595 |
| 114 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77137437 |
| 115 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.76637919 |
| 116 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.76063345 |
| 117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.75629889 |
| 118 | SPI1_23127762_ChIP-Seq_K562_Human | 0.75111134 |
| 119 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.75106290 |
| 120 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.74268956 |
| 121 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73047294 |
| 122 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.71245714 |
| 123 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.70582888 |
| 124 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.70325842 |
| 125 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.69939136 |
| 126 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.69241972 |
| 127 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.65575991 |
| 128 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63665975 |
| 129 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.63576075 |
| 130 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.63456827 |
| 131 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.61586786 |
| 132 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.61522818 |
| 133 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61431142 |
| 134 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61375713 |
| 135 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.60386729 |
| 136 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.58522910 |
| 137 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57628818 |
| 138 | CBP_21632823_ChIP-Seq_H3396_Human | 0.57286513 |
| 139 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.56726753 |
| 140 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56314962 |
| 141 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.56157856 |
| 142 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.55983961 |
| 143 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.55164342 |
| 144 | GATA2_19941826_ChIP-Seq_K562_Human | 0.53853177 |
| 145 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53841652 |
| 146 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.53640741 |
| 147 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.51741459 |
| 148 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.51214107 |
| 149 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.51140717 |
| 150 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.50969010 |
| 151 | GATA1_19941826_ChIP-Seq_K562_Human | 0.50561434 |
| 152 | RXR_22108803_ChIP-Seq_LS180_Human | 0.50322682 |
| 153 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.49848452 |
| 154 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49828425 |
| 155 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.49439598 |
| 156 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.48878175 |
| 157 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48068049 |
| 158 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.46340882 |
| 159 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.45996120 |
| 160 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.45794453 |
| 161 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.45423671 |
| 162 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.45367297 |
| 163 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.44065204 |
| 164 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.43581844 |
| 165 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.43183844 |
| 166 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43161491 |
| 167 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.42937038 |
| 168 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.42192564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.27089695 |
| 2 | MP0005360_urolithiasis | 7.20624295 |
| 3 | MP0005365_abnormal_bile_salt | 5.42865214 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.28203202 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.40370590 |
| 6 | MP0004145_abnormal_muscle_electrophysio | 4.00588427 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.46447018 |
| 8 | MP0005332_abnormal_amino_acid | 3.40833829 |
| 9 | MP0003252_abnormal_bile_duct | 3.39456334 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.39292702 |
| 11 | MP0000749_muscle_degeneration | 2.99107466 |
| 12 | MP0003195_calcinosis | 2.75415411 |
| 13 | MP0004084_abnormal_cardiac_muscle | 2.74525044 |
| 14 | MP0009840_abnormal_foam_cell | 2.70454160 |
| 15 | MP0005670_abnormal_white_adipose | 2.53121531 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.46900521 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.32051714 |
| 18 | MP0005083_abnormal_biliary_tract | 2.30753739 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.23835442 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.19311574 |
| 21 | MP0000609_abnormal_liver_physiology | 2.00082544 |
| 22 | MP0004130_abnormal_muscle_cell | 1.97090242 |
| 23 | MP0004484_altered_response_of | 1.95434433 |
| 24 | MP0002106_abnormal_muscle_physiology | 1.89551614 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.87302362 |
| 26 | MP0002132_abnormal_respiratory_system | 1.85595199 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.85029045 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.83278351 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.77247752 |
| 30 | MP0005666_abnormal_adipose_tissue | 1.72006716 |
| 31 | MP0003186_abnormal_redox_activity | 1.68410182 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.68202134 |
| 33 | MP0002127_abnormal_cardiovascular_syste | 1.64482615 |
| 34 | MP0005369_muscle_phenotype | 1.59083705 |
| 35 | MP0001764_abnormal_homeostasis | 1.57325641 |
| 36 | MP0004043_abnormal_pH_regulation | 1.53082871 |
| 37 | MP0001835_abnormal_antigen_presentation | 1.51240294 |
| 38 | MP0000759_abnormal_skeletal_muscle | 1.47974479 |
| 39 | MP0002971_abnormal_brown_adipose | 1.42434293 |
| 40 | MP0000013_abnormal_adipose_tissue | 1.39257569 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.33382481 |
| 42 | MP0003868_abnormal_feces_composition | 1.31447021 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.28115494 |
| 44 | MP0003646_muscle_fatigue | 1.26631731 |
| 45 | MP0003690_abnormal_glial_cell | 1.23020625 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.22140384 |
| 47 | MP0005451_abnormal_body_composition | 1.21555885 |
| 48 | MP0005535_abnormal_body_temperature | 1.21293514 |
| 49 | MP0005636_abnormal_mineral_homeostasis | 1.21290731 |
| 50 | MP0005646_abnormal_pituitary_gland | 1.19633155 |
| 51 | MP0000747_muscle_weakness | 1.16480117 |
| 52 | MP0003828_pulmonary_edema | 1.15922913 |
| 53 | MP0001756_abnormal_urination | 1.14950279 |
| 54 | MP0002254_reproductive_system_inflammat | 1.14282416 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.09947514 |
| 56 | MP0003137_abnormal_impulse_conducting | 1.09816281 |
| 57 | MP0003011_delayed_dark_adaptation | 1.09479281 |
| 58 | MP0005647_abnormal_sex_gland | 1.08358375 |
| 59 | MP0000604_amyloidosis | 1.03828425 |
| 60 | MP0005334_abnormal_fat_pad | 1.03020331 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 1.02717029 |
| 62 | MP0001661_extended_life_span | 1.01669160 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 1.00083149 |
| 64 | MP0010630_abnormal_cardiac_muscle | 0.99068085 |
| 65 | MP0000598_abnormal_liver_morphology | 0.98311474 |
| 66 | MP0009764_decreased_sensitivity_to | 0.97931557 |
| 67 | MP0000372_irregular_coat_pigmentation | 0.97744971 |
| 68 | MP0001986_abnormal_taste_sensitivity | 0.93854020 |
| 69 | MP0005375_adipose_tissue_phenotype | 0.93748611 |
| 70 | MP0003879_abnormal_hair_cell | 0.93657231 |
| 71 | MP0004510_myositis | 0.92156592 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 0.91925659 |
| 73 | MP0004147_increased_porphyrin_level | 0.91431053 |
| 74 | MP0003329_amyloid_beta_deposits | 0.91401237 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 0.90451956 |
| 76 | MP0009697_abnormal_copulation | 0.90448951 |
| 77 | MP0002136_abnormal_kidney_physiology | 0.90164346 |
| 78 | MP0009642_abnormal_blood_homeostasis | 0.85869137 |
| 79 | MP0000750_abnormal_muscle_regeneration | 0.85298898 |
| 80 | MP0009115_abnormal_fat_cell | 0.84972901 |
| 81 | MP0004085_abnormal_heartbeat | 0.83231071 |
| 82 | MP0009763_increased_sensitivity_to | 0.82376810 |
| 83 | MP0005058_abnormal_lysosome_morphology | 0.81961267 |
| 84 | MP0001800_abnormal_humoral_immune | 0.81132596 |
| 85 | MP0005551_abnormal_eye_electrophysiolog | 0.80945904 |
| 86 | MP0001765_abnormal_ion_homeostasis | 0.80348400 |
| 87 | MP0005671_abnormal_response_to | 0.80008545 |
| 88 | MP0002108_abnormal_muscle_morphology | 0.78943353 |
| 89 | MP0001968_abnormal_touch/_nociception | 0.78818687 |
| 90 | MP0003045_fibrosis | 0.78385149 |
| 91 | MP0005000_abnormal_immune_tolerance | 0.78366266 |
| 92 | MP0003303_peritoneal_inflammation | 0.77428369 |
| 93 | MP0005376_homeostasis/metabolism_phenot | 0.76646869 |
| 94 | MP0008469_abnormal_protein_level | 0.74801756 |
| 95 | MP0009785_altered_susceptibility_to | 0.74487832 |
| 96 | MP0002148_abnormal_hypersensitivity_rea | 0.73899508 |
| 97 | MP0008872_abnormal_physiological_respon | 0.73269609 |
| 98 | MP0005084_abnormal_gallbladder_morpholo | 0.72165306 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.71934923 |
| 100 | MP0005330_cardiomyopathy | 0.71284252 |
| 101 | MP0005266_abnormal_metabolism | 0.71036782 |
| 102 | MP0002638_abnormal_pupillary_reflex | 0.69841239 |
| 103 | MP0006035_abnormal_mitochondrial_morpho | 0.69653962 |
| 104 | MP0005448_abnormal_energy_balance | 0.68646268 |
| 105 | MP0001984_abnormal_olfaction | 0.68196236 |
| 106 | MP0000249_abnormal_blood_vessel | 0.67331676 |
| 107 | MP0005645_abnormal_hypothalamus_physiol | 0.67019627 |
| 108 | MP0005025_abnormal_response_to | 0.65933674 |
| 109 | MP0002723_abnormal_immune_serum | 0.64636806 |
| 110 | MP0002970_abnormal_white_adipose | 0.61859225 |
| 111 | MP0003075_altered_response_to | 0.59104412 |
| 112 | MP0009384_cardiac_valve_regurgitation | 0.57929302 |
| 113 | MP0002168_other_aberrant_phenotype | 0.57398845 |
| 114 | MP0003953_abnormal_hormone_level | 0.57041875 |
| 115 | MP0010368_abnormal_lymphatic_system | 0.56833095 |
| 116 | MP0001853_heart_inflammation | 0.55226307 |
| 117 | MP0005220_abnormal_exocrine_pancreas | 0.54493485 |
| 118 | MP0006138_congestive_heart_failure | 0.54110289 |
| 119 | MP0002269_muscular_atrophy | 0.52256684 |
| 120 | MP0003959_abnormal_lean_body | 0.51785268 |
| 121 | MP0002332_abnormal_exercise_endurance | 0.51593891 |
| 122 | MP0004215_abnormal_myocardial_fiber | 0.50022964 |
| 123 | MP0003724_increased_susceptibility_to | 0.49920419 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.49124999 |
| 125 | MP0003638_abnormal_response/metabolism_ | 0.49007397 |
| 126 | MP0004036_abnormal_muscle_relaxation | 0.48886880 |
| 127 | MP0005385_cardiovascular_system_phenoty | 0.46852011 |
| 128 | MP0001544_abnormal_cardiovascular_syste | 0.46852011 |
| 129 | MP0005620_abnormal_muscle_contractility | 0.46792151 |
| 130 | MP0005408_hypopigmentation | 0.46555458 |
| 131 | MP0008961_abnormal_basal_metabolism | 0.46027050 |
| 132 | MP0000751_myopathy | 0.44884495 |
| 133 | MP0008874_decreased_physiological_sensi | 0.44204491 |
| 134 | MP0005395_other_phenotype | 0.44163719 |
| 135 | MP0002972_abnormal_cardiac_muscle | 0.43418124 |
| 136 | MP0005165_increased_susceptibility_to | 0.43184214 |
| 137 | MP0004087_abnormal_muscle_fiber | 0.42091160 |
| 138 | MP0008775_abnormal_heart_ventricle | 0.41994928 |
| 139 | MP0002928_abnormal_bile_duct | 0.40812126 |
| 140 | MP0005167_abnormal_blood-brain_barrier | 0.40688261 |
| 141 | MP0005595_abnormal_vascular_smooth | 0.40662588 |
| 142 | MP0005452_abnormal_adipose_tissue | 0.40504154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 6.72979339 |
| 2 | Nemaline bodies (HP:0003798) | 6.61501153 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.46405697 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.77949299 |
| 5 | Hyperglycinuria (HP:0003108) | 5.71816537 |
| 6 | Exercise-induced myalgia (HP:0003738) | 5.65383247 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 5.55737615 |
| 8 | Xanthomatosis (HP:0000991) | 5.42926485 |
| 9 | Deep venous thrombosis (HP:0002625) | 5.28531016 |
| 10 | Abnormality of glycine metabolism (HP:0010895) | 5.26145632 |
| 11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.26145632 |
| 12 | Ketosis (HP:0001946) | 5.01362935 |
| 13 | Hyperammonemia (HP:0001987) | 4.90626874 |
| 14 | Hyperglycinemia (HP:0002154) | 4.90349063 |
| 15 | Type 1 muscle fiber predominance (HP:0003803) | 4.78974998 |
| 16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.78938127 |
| 17 | Exercise-induced muscle cramps (HP:0003710) | 4.78544602 |
| 18 | Hyperlipoproteinemia (HP:0010980) | 4.69981480 |
| 19 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.63929078 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.56365546 |
| 21 | Ketoacidosis (HP:0001993) | 4.44368488 |
| 22 | Prolonged partial thromboplastin time (HP:0003645) | 4.41272458 |
| 23 | Hypoglycemic coma (HP:0001325) | 4.34886160 |
| 24 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.31162175 |
| 25 | Complement deficiency (HP:0004431) | 4.27104376 |
| 26 | Hypobetalipoproteinemia (HP:0003563) | 4.23068309 |
| 27 | Sudden death (HP:0001699) | 4.04651384 |
| 28 | Calf muscle hypertrophy (HP:0008981) | 4.03730674 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 3.96043088 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.92203681 |
| 31 | EMG: myopathic abnormalities (HP:0003458) | 3.88091140 |
| 32 | Hypolipoproteinemia (HP:0010981) | 3.83905370 |
| 33 | Hyporeflexia of lower limbs (HP:0002600) | 3.81754337 |
| 34 | Gout (HP:0001997) | 3.80661335 |
| 35 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.78166876 |
| 36 | Epidermoid cyst (HP:0200040) | 3.77300942 |
| 37 | Muscle fiber splitting (HP:0003555) | 3.70842717 |
| 38 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.58708832 |
| 39 | Dicarboxylic aciduria (HP:0003215) | 3.54621346 |
| 40 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.54621346 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.53525138 |
| 42 | Asymmetric septal hypertrophy (HP:0001670) | 3.52385847 |
| 43 | Distal arthrogryposis (HP:0005684) | 3.49509728 |
| 44 | Abnormality of purine metabolism (HP:0004352) | 3.46357542 |
| 45 | Bundle branch block (HP:0011710) | 3.43555658 |
| 46 | Abnormality of the calf musculature (HP:0001430) | 3.41698986 |
| 47 | Joint hemorrhage (HP:0005261) | 3.40186958 |
| 48 | Neck muscle weakness (HP:0000467) | 3.33241906 |
| 49 | Abnormality of serum amino acid levels (HP:0003112) | 3.28562643 |
| 50 | Abnormality of methionine metabolism (HP:0010901) | 3.27575047 |
| 51 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.27147121 |
| 52 | Subaortic stenosis (HP:0001682) | 3.27147121 |
| 53 | Delayed CNS myelination (HP:0002188) | 3.25529632 |
| 54 | Generalized aminoaciduria (HP:0002909) | 3.23762908 |
| 55 | Metabolic acidosis (HP:0001942) | 3.17038295 |
| 56 | Abnormality of nucleobase metabolism (HP:0010932) | 3.16321773 |
| 57 | Rimmed vacuoles (HP:0003805) | 3.14032506 |
| 58 | Proximal tubulopathy (HP:0000114) | 3.12212380 |
| 59 | Fat malabsorption (HP:0002630) | 3.07813945 |
| 60 | Abnormality of the common coagulation pathway (HP:0010990) | 3.05825703 |
| 61 | Lethargy (HP:0001254) | 3.03656327 |
| 62 | Abnormality of complement system (HP:0005339) | 2.94709538 |
| 63 | Hyperuricemia (HP:0002149) | 2.94444556 |
| 64 | Increased purine levels (HP:0004368) | 2.94444556 |
| 65 | Heart block (HP:0012722) | 2.93298028 |
| 66 | Hypercholesterolemia (HP:0003124) | 2.92931336 |
| 67 | Myotonia (HP:0002486) | 2.92239654 |
| 68 | Ventricular tachycardia (HP:0004756) | 2.86754878 |
| 69 | Hydroxyprolinuria (HP:0003080) | 2.85640489 |
| 70 | Abnormality of proline metabolism (HP:0010907) | 2.85640489 |
| 71 | Myopathic facies (HP:0002058) | 2.81365955 |
| 72 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.79153871 |
| 73 | Cerebral edema (HP:0002181) | 2.77299708 |
| 74 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.66707320 |
| 75 | Hyperbilirubinemia (HP:0002904) | 2.64878231 |
| 76 | Vomiting (HP:0002013) | 2.64542995 |
| 77 | Myoglobinuria (HP:0002913) | 2.64258848 |
| 78 | Round ear (HP:0100830) | 2.62492845 |
| 79 | Abnormality of the intrinsic pathway (HP:0010989) | 2.60935265 |
| 80 | Abnormal atrioventricular conduction (HP:0005150) | 2.60632808 |
| 81 | Muscle stiffness (HP:0003552) | 2.59237412 |
| 82 | Myocardial infarction (HP:0001658) | 2.57573565 |
| 83 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.56250235 |
| 84 | Vascular calcification (HP:0004934) | 2.56186670 |
| 85 | Areflexia of lower limbs (HP:0002522) | 2.55140815 |
| 86 | Atrioventricular block (HP:0001678) | 2.55055749 |
| 87 | Conjugated hyperbilirubinemia (HP:0002908) | 2.54463411 |
| 88 | Frequent falls (HP:0002359) | 2.51570399 |
| 89 | Skin nodule (HP:0200036) | 2.49874429 |
| 90 | Alkalosis (HP:0001948) | 2.48952217 |
| 91 | Difficulty running (HP:0009046) | 2.47734972 |
| 92 | Sensorimotor neuropathy (HP:0007141) | 2.46157891 |
| 93 | Facial diplegia (HP:0001349) | 2.43964980 |
| 94 | Hepatocellular carcinoma (HP:0001402) | 2.42904834 |
| 95 | Ulnar deviation of the wrist (HP:0003049) | 2.39175770 |
| 96 | Late onset (HP:0003584) | 2.38336314 |
| 97 | Dilated cardiomyopathy (HP:0001644) | 2.37004564 |
| 98 | Hypoglycemic seizures (HP:0002173) | 2.35364132 |
| 99 | Distal lower limb muscle weakness (HP:0009053) | 2.33864657 |
| 100 | Syncope (HP:0001279) | 2.32712760 |
| 101 | Enlarged kidneys (HP:0000105) | 2.32112400 |
| 102 | Steatorrhea (HP:0002570) | 2.31473241 |
| 103 | Glycosuria (HP:0003076) | 2.31269940 |
| 104 | Abnormality of urine glucose concentration (HP:0011016) | 2.31269940 |
| 105 | Pancreatitis (HP:0001733) | 2.31028744 |
| 106 | Gingival bleeding (HP:0000225) | 2.29360404 |
| 107 | Cardiovascular calcification (HP:0011915) | 2.29030469 |
| 108 | Systemic lupus erythematosus (HP:0002725) | 2.27177472 |
| 109 | Generalized muscle weakness (HP:0003324) | 2.26544893 |
| 110 | Nausea (HP:0002018) | 2.26471749 |
| 111 | EMG: neuropathic changes (HP:0003445) | 2.25776795 |
| 112 | Irritability (HP:0000737) | 2.24370828 |
| 113 | Ventricular arrhythmia (HP:0004308) | 2.23633833 |
| 114 | Neonatal onset (HP:0003623) | 2.22599841 |
| 115 | Atrial fibrillation (HP:0005110) | 2.20052362 |
| 116 | Lipoatrophy (HP:0100578) | 2.18896773 |
| 117 | Decreased central vision (HP:0007663) | 2.17842066 |
| 118 | Increased variability in muscle fiber diameter (HP:0003557) | 2.16748011 |
| 119 | Spastic diplegia (HP:0001264) | 2.15818219 |
| 120 | Hypertriglyceridemia (HP:0002155) | 2.15814257 |
| 121 | Renal cortical cysts (HP:0000803) | 2.13618790 |
| 122 | Methylmalonic aciduria (HP:0012120) | 2.11076412 |
| 123 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.09374343 |
| 124 | Hypokalemic alkalosis (HP:0001949) | 2.08712185 |
| 125 | Absent phalangeal crease (HP:0006109) | 2.08525272 |
| 126 | Malnutrition (HP:0004395) | 2.08190182 |
| 127 | Primary atrial arrhythmia (HP:0001692) | 2.06876272 |
| 128 | Gowers sign (HP:0003391) | 2.05053715 |
| 129 | Increased intramyocellular lipid droplets (HP:0012240) | 2.04275679 |
| 130 | Cholelithiasis (HP:0001081) | 2.03864685 |
| 131 | Abnormal gallbladder morphology (HP:0012437) | 2.03243925 |
| 132 | Rhabdomyolysis (HP:0003201) | 1.99362119 |
| 133 | Chest pain (HP:0100749) | 1.95866130 |
| 134 | Increased circulating renin level (HP:0000848) | 1.92598034 |
| 135 | Hepatic necrosis (HP:0002605) | 1.91602662 |
| 136 | Supraventricular tachycardia (HP:0004755) | 1.91278290 |
| 137 | Epistaxis (HP:0000421) | 1.89277870 |
| 138 | Abnormal cartilage morphology (HP:0002763) | 1.89018980 |
| 139 | Prolonged bleeding time (HP:0003010) | 1.88521381 |
| 140 | Ragged-red muscle fibers (HP:0003200) | 1.88461878 |
| 141 | Brushfield spots (HP:0001088) | 1.88351083 |
| 142 | Amyloidosis (HP:0011034) | 1.87400730 |
| 143 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.87159522 |
| 144 | Esophageal varix (HP:0002040) | 1.86734324 |
| 145 | Rickets (HP:0002748) | 1.86488260 |
| 146 | Hemorrhage of the eye (HP:0011885) | 1.84889352 |
| 147 | Supraventricular arrhythmia (HP:0005115) | 1.83978732 |
| 148 | Acute encephalopathy (HP:0006846) | 1.83763756 |
| 149 | Mitral stenosis (HP:0001718) | 1.83495960 |
| 150 | Increased muscle lipid content (HP:0009058) | 1.82510846 |
| 151 | Spontaneous abortion (HP:0005268) | 1.81800418 |
| 152 | Oligomenorrhea (HP:0000876) | 1.81201842 |
| 153 | Metabolic alkalosis (HP:0200114) | 1.80988930 |
| 154 | Abnormal urine output (HP:0012590) | 1.79794494 |
| 155 | Back pain (HP:0003418) | 1.79690653 |
| 156 | Cerebral palsy (HP:0100021) | 1.79189434 |
| 157 | Increased connective tissue (HP:0009025) | 1.76591953 |
| 158 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.75892217 |
| 159 | Abnormal finger flexion creases (HP:0006143) | 1.75489394 |
| 160 | Elevated hepatic transaminases (HP:0002910) | 1.75288123 |
| 161 | Nephrolithiasis (HP:0000787) | 1.74715850 |
| 162 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.70809354 |
| 163 | Weak cry (HP:0001612) | 1.68968368 |
| 164 | Malignant hyperthermia (HP:0002047) | 1.66581884 |
| 165 | Palpitations (HP:0001962) | 1.65927231 |
| 166 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.65679900 |
| 167 | Abnormality of the prostate (HP:0008775) | 1.64226263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.91120241 |
| 2 | SIK1 | 4.05879983 |
| 3 | TRIB3 | 3.52499993 |
| 4 | ERN1 | 3.10472628 |
| 5 | FGFR4 | 2.83399301 |
| 6 | PDK4 | 2.67598595 |
| 7 | PDK3 | 2.67598595 |
| 8 | WNK4 | 2.58569668 |
| 9 | INSRR | 2.42114259 |
| 10 | LMTK2 | 2.19973276 |
| 11 | WNK3 | 2.16337794 |
| 12 | TXK | 2.11956330 |
| 13 | PKN2 | 1.95053238 |
| 14 | MST1R | 1.89604722 |
| 15 | PINK1 | 1.88330204 |
| 16 | FES | 1.87636193 |
| 17 | CAMK1D | 1.84601027 |
| 18 | OXSR1 | 1.78474534 |
| 19 | MAP4K2 | 1.78290594 |
| 20 | KIT | 1.77540480 |
| 21 | PDK2 | 1.75559427 |
| 22 | MAPKAPK3 | 1.72170097 |
| 23 | PHKG2 | 1.68797492 |
| 24 | PHKG1 | 1.68797492 |
| 25 | ITK | 1.55485514 |
| 26 | ERBB4 | 1.52854444 |
| 27 | PRKAA2 | 1.52735723 |
| 28 | TEC | 1.43125364 |
| 29 | MAP2K4 | 1.42389093 |
| 30 | STK38L | 1.37336854 |
| 31 | MAPK11 | 1.35315075 |
| 32 | MAP4K1 | 1.33145038 |
| 33 | SYK | 1.26813416 |
| 34 | CAMK1G | 1.26690864 |
| 35 | TRPM7 | 1.26228553 |
| 36 | MUSK | 1.25110664 |
| 37 | LATS1 | 1.24386786 |
| 38 | NEK9 | 1.24251246 |
| 39 | IKBKE | 1.23485082 |
| 40 | MAP3K7 | 1.17074356 |
| 41 | TAOK3 | 1.15636452 |
| 42 | TNK2 | 1.15202196 |
| 43 | SGK3 | 1.10938099 |
| 44 | TIE1 | 1.09859566 |
| 45 | SGK494 | 1.09721839 |
| 46 | SGK223 | 1.09721839 |
| 47 | BTK | 1.09376939 |
| 48 | CSF1R | 1.08384815 |
| 49 | BLK | 1.05765053 |
| 50 | PRKAA1 | 1.03677208 |
| 51 | SGK2 | 1.00828632 |
| 52 | NEK1 | 1.00615032 |
| 53 | ZAP70 | 1.00102845 |
| 54 | MAPK12 | 0.99470435 |
| 55 | ADRBK2 | 0.99288354 |
| 56 | PTK6 | 0.99139087 |
| 57 | FGFR2 | 0.98545062 |
| 58 | FRK | 0.96897893 |
| 59 | FLT3 | 0.96826950 |
| 60 | TTN | 0.96444019 |
| 61 | PIK3CG | 0.95439019 |
| 62 | ABL2 | 0.91661421 |
| 63 | PRKG2 | 0.91308339 |
| 64 | IRAK3 | 0.91290785 |
| 65 | STK39 | 0.87540359 |
| 66 | TYK2 | 0.86338246 |
| 67 | RIPK1 | 0.85708108 |
| 68 | JAK2 | 0.85492511 |
| 69 | RIPK4 | 0.83713547 |
| 70 | DYRK1B | 0.81510183 |
| 71 | EPHB1 | 0.80984424 |
| 72 | EPHA4 | 0.80913797 |
| 73 | TGFBR2 | 0.79564653 |
| 74 | MAP3K14 | 0.79523268 |
| 75 | JAK1 | 0.78285342 |
| 76 | OBSCN | 0.77670939 |
| 77 | DAPK2 | 0.77199769 |
| 78 | PDPK1 | 0.77051017 |
| 79 | ERBB3 | 0.76024031 |
| 80 | CAMK1 | 0.75977658 |
| 81 | MAPK13 | 0.75500209 |
| 82 | PRKACG | 0.75076390 |
| 83 | GRK1 | 0.74683808 |
| 84 | MET | 0.74647465 |
| 85 | LCK | 0.74373005 |
| 86 | NTRK3 | 0.73380036 |
| 87 | IKBKB | 0.72734773 |
| 88 | PRKG1 | 0.72611578 |
| 89 | LYN | 0.72195191 |
| 90 | TNIK | 0.71643049 |
| 91 | MYLK | 0.69335883 |
| 92 | PIK3CA | 0.69223885 |
| 93 | GSK3A | 0.69210750 |
| 94 | NLK | 0.68312142 |
| 95 | HCK | 0.68127998 |
| 96 | CAMK2D | 0.68025329 |
| 97 | FGFR3 | 0.63003480 |
| 98 | STK38 | 0.60638605 |
| 99 | PRKCZ | 0.60609115 |
| 100 | IRAK1 | 0.60554692 |
| 101 | NUAK1 | 0.60481283 |
| 102 | MAP2K3 | 0.59621013 |
| 103 | GRK6 | 0.59569216 |
| 104 | MAPK15 | 0.59076923 |
| 105 | MAPK4 | 0.58714224 |
| 106 | PDK1 | 0.55969949 |
| 107 | CAMK2A | 0.54859633 |
| 108 | ROCK1 | 0.52964149 |
| 109 | MAP3K13 | 0.51164958 |
| 110 | KDR | 0.50465434 |
| 111 | MAP2K1 | 0.50030479 |
| 112 | PAK3 | 0.49035202 |
| 113 | TLK1 | 0.47940612 |
| 114 | IRAK2 | 0.47245633 |
| 115 | MAP2K2 | 0.47091806 |
| 116 | CAMK2G | 0.44143633 |
| 117 | EIF2AK3 | 0.43854851 |
| 118 | BMPR1B | 0.43636696 |
| 119 | IGF1R | 0.43228867 |
| 120 | MAP3K1 | 0.42801509 |
| 121 | GRK7 | 0.42657753 |
| 122 | JAK3 | 0.42368718 |
| 123 | MAP3K6 | 0.42358320 |
| 124 | MAP3K3 | 0.41951045 |
| 125 | PRKD1 | 0.41371704 |
| 126 | TAOK2 | 0.41052392 |
| 127 | PRKD2 | 0.41004254 |
| 128 | CDK6 | 0.41000151 |
| 129 | TBK1 | 0.40502321 |
| 130 | PRKCE | 0.39843710 |
| 131 | DMPK | 0.39539265 |
| 132 | ERBB2 | 0.38419754 |
| 133 | MAPK7 | 0.38267220 |
| 134 | BMX | 0.37981691 |
| 135 | ADRBK1 | 0.36960628 |
| 136 | PRKCQ | 0.36368241 |
| 137 | PDGFRA | 0.35789677 |
| 138 | RET | 0.34697731 |
| 139 | MAP2K6 | 0.33428328 |
| 140 | CSK | 0.31099222 |
| 141 | PRKCH | 0.30997322 |
| 142 | LRRK2 | 0.30251854 |
| 143 | PTK2 | 0.29737317 |
| 144 | MAP3K5 | 0.29359299 |
| 145 | PRKACA | 0.27691104 |
| 146 | MTOR | 0.27505986 |
| 147 | PKN1 | 0.26378687 |
| 148 | EPHA3 | 0.26117376 |
| 149 | SGK1 | 0.25854653 |
| 150 | CAMK4 | 0.25732273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.65280914 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.53200473 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.08120384 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.02122004 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.97447530 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.90760123 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.89392265 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.88344945 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.63130252 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.60198521 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.55840827 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.53884203 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.42723220 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.32821622 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.32202901 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.26589895 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.26261579 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.11067569 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.06470735 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.97090729 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.89232058 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.86425484 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.79328420 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.74068962 |
| 25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.59738039 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.57885462 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.56194900 |
| 28 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.54164602 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.51936717 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.51880774 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.50128014 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.50014230 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.49134152 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.48114621 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.45254748 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.44557503 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43874443 |
| 38 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.41680027 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.41653950 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.41473621 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.40649500 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38897952 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38091249 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29417980 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.28034872 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26504161 |
| 47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.25747399 |
| 48 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.24205459 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23422164 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.22898712 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21877950 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.21615332 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12799224 |
| 54 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12646386 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11153688 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09026577 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08697554 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04569618 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00831251 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00354602 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 0.93338711 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.92267761 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.90835030 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90577995 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.90565414 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.83570377 |
| 67 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.83534315 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81799198 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79037128 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.78676518 |
| 71 | Renin secretion_Homo sapiens_hsa04924 | 0.77117792 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76743561 |
| 73 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.74830008 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72965192 |
| 75 | Phototransduction_Homo sapiens_hsa04744 | 0.69529175 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67304400 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.64643960 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64212002 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64127975 |
| 80 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62598449 |
| 81 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.60796759 |
| 82 | Leishmaniasis_Homo sapiens_hsa05140 | 0.59621292 |
| 83 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.54634901 |
| 84 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54472340 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53779968 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.52645546 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49784141 |
| 88 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49711102 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48155177 |
| 90 | Circadian entrainment_Homo sapiens_hsa04713 | 0.44002850 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.41651677 |
| 92 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41204875 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40600219 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.39249807 |
| 95 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.38265292 |
| 96 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.34580151 |
| 97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34402473 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34092463 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29587941 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.28599183 |
| 101 | Olfactory transduction_Homo sapiens_hsa04740 | 0.28476010 |
| 102 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.28245015 |
| 103 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.27899014 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27620291 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.27526671 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.27388424 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26556881 |
| 108 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.26339004 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22047481 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.13684538 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.10808747 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.08841654 |
| 113 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.08425766 |
| 114 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.08289223 |
| 115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08260836 |
| 116 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.05519072 |
| 117 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.01392307 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.01096670 |
| 119 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1249275 |
| 120 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.1226100 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1102120 |
| 122 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0988066 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0967919 |
| 124 | Lysosome_Homo sapiens_hsa04142 | -0.0951230 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0862175 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0843846 |
| 127 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0823427 |
| 128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0802960 |
| 129 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0742186 |
| 130 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0732252 |
| 131 | Mineral absorption_Homo sapiens_hsa04978 | -0.0661551 |
| 132 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0459545 |
| 133 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0225457 |

